PJT Partners (PJT) Getting Somewhat Favorable News Coverage, Report Finds

Media stories about PJT Partners (NYSE:PJT) have been trending somewhat positive recently, according to Accern. Accern rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. PJT Partners earned a coverage optimism score of 0.04 on Accern’s scale. Accern also assigned media stories about the financial services provider an impact score of 46.0482466512188 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Here are some of the media stories that may have effected Accern Sentiment’s rankings:

How to Become a New Pot Stock Millionaire

PJT opened at $53.75 on Friday. The company has a market cap of $998.43, a PE ratio of 34.90, a PEG ratio of 0.79 and a beta of 0.36. PJT Partners has a 52-week low of $32.61 and a 52-week high of $54.00.

PJT Partners (NYSE:PJT) last posted its quarterly earnings data on Wednesday, February 7th. The financial services provider reported $0.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.12. The company had revenue of $190.55 million for the quarter. PJT Partners had a negative net margin of 6.52% and a positive return on equity of 319.40%. sell-side analysts forecast that PJT Partners will post 2.5 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 21st. Stockholders of record on Wednesday, March 7th were paid a dividend of $0.05 per share. The ex-dividend date of this dividend was Tuesday, March 6th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.37%. PJT Partners’s dividend payout ratio is currently 12.99%.

A number of brokerages have weighed in on PJT. Zacks Investment Research cut shares of PJT Partners from a “buy” rating to a “hold” rating in a research report on Tuesday, March 13th. Sandler O’Neill set a $55.00 price objective on shares of PJT Partners and gave the company a “buy” rating in a research note on Thursday, January 11th. Finally, Buckingham Research assumed coverage on shares of PJT Partners in a research note on Wednesday, January 3rd. They set a “neutral” rating and a $51.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $50.20.

In other news, General Counsel James W. Cuminale sold 2,816 shares of PJT Partners stock in a transaction that occurred on Tuesday, March 6th. The shares were sold at an average price of $48.05, for a total transaction of $135,308.80. Following the sale, the general counsel now owns 49,502 shares in the company, valued at $2,378,571.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 8.01% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “PJT Partners (PJT) Getting Somewhat Favorable News Coverage, Report Finds” was first published by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another domain, it was illegally copied and republished in violation of international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3335193/pjt-partners-pjt-getting-somewhat-favorable-news-coverage-report-finds.html.

About PJT Partners

PJT Partners Inc provides various strategic advisory, restructuring and special situations, and private fund advisory and placement services to corporations, financial sponsors, institutional investors, and governments worldwide. It offers a range of financial advisory and transaction execution capability, including mergers and acquisitions, joint ventures, minority investments, asset swaps, divestitures, takeover defenses, corporate finance advisory, private placements, and distressed sales.

Insider Buying and Selling by Quarter for PJT Partners (NYSE:PJT)

Receive News & Ratings for PJT Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PJT Partners and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Cantor Fitzgerald Raises Intuitive Surgical  Price Target to $510.00
Cantor Fitzgerald Raises Intuitive Surgical Price Target to $510.00
JPMorgan Chase Boosts UnitedHealth Group  Price Target to $266.00
JPMorgan Chase Boosts UnitedHealth Group Price Target to $266.00
Mizuho Reaffirms “Buy” Rating for QUALCOMM
Mizuho Reaffirms “Buy” Rating for QUALCOMM
Noah  and PJT Partners  Critical Review
Noah and PJT Partners Critical Review
Head-To-Head Analysis: The Meet Group  & Quotient Technology
Head-To-Head Analysis: The Meet Group & Quotient Technology
Mersana Therapeutics  Stock Rating Upgraded by Zacks Investment Research
Mersana Therapeutics Stock Rating Upgraded by Zacks Investment Research


© 2006-2018 Ticker Report. Google+.